Mobile Menu

Round-up: COVID-19 February 2021 (Part One)

As vaccines are rolled out, researchers continue to keep up with the virus that is still rampaging across the world. Here, we provide you with the latest round-up of COVID-19 news and research from the past fortnight.


At the time of writing, there have been:

  • 105,471,226 cases
  • 2,296,080 deaths
  • 77,171,970 recoveries


  • New research demonstrates that antibodies generated by the novel coronavirus react to other strains of coronavirus and vice versa. (Tafesse et al, 2021)
  • A new study suggests that T cells target a broad range of sites on the virus, meaning they may potentially recognise different SARS-CoV-2 variants. (Sette et al, 2021)
  • Scientists uncover how remdesivir works – revealing that it is a delayed translocation inhibitor of SARS-CoV-2 replication. (Johnson et al, 2021)
  • Researchers have developed a new protein that tricks and neutralises COVID-19 in a human kidney organoid. (Battle et al, 2021)
  • New protein-based biosensors can detect coronavirus proteins and antibodies within minutes. (Baker et al, 2021)
  • A team of researchers have developed a novel strategy that redirects antibodies for other diseases existing in humans to the spike proteins of SARS-CoV-2. (Han et al, 2021)
  • Researchers have described how electronic health records can be valuable predictors of those likeliest to die from COVID-19. (Estiri et al, 2021)

Other news

Image credit: By starline –

More on these topics

Coronavirus / covid-19 / Round-up